Abstract
ABSTRACTCaseChemotherapy‐induced peripheral neuropathy (CIPN) frequently occurs in cancer patients due to neurotoxic anti‐cancer drugs and is associated with painful refractory symptoms. Aconiti tuber (bushi), a Japanese herbal medicine, is an analgesic agent. The objective of this study was to investigate the efficacy of bushi for CIPN among cancer patients. We retrospectively analyzed cancer patients who visited our hospital and were administered bushi for CIPN between January 2020 and November 2020. We analyzed efficacy and adverse events by medical chart review.OutcomeSeven cancer patients (mean age 67.9 years, three females) were enrolled. The following neurotoxic anti‐cancer agents were administered: platinum analogues (n = 6), taxanes (n = 2), proteasome inhibitors (n = 1). Bushi was evaluated as effective in four patients (57.1%). One patient (9.1%) discontinued treatment because of adverse events (bad feeling). No other adverse events were reported.ConclusionBushi is effective for CIPN in cancer patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
